RESTful Lookup — Test-Drive (2007 – 2026)

{
  "NDC": [
    {
      "NDCCode": "21130-472-68",
      "PackageDescription": "72 TABLET, CHEWABLE in 1 BOTTLE (21130-472-68)",
      "NDC11Code": "21130-0472-68",
      "ProductNDC": "21130-472",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Antacid Relief",
      "NonProprietaryName": "Calcium Carbonate",
      "DosageFormName": "TABLET, CHEWABLE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20151111",
      "MarketingCategoryName": "OTC MONOGRAPH FINAL",
      "ApplicationNumber": "part331",
      "LabelerName": "Safeway",
      "SubstanceName": "CALCIUM CARBONATE",
      "StrengthNumber": "1000",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]",
      "Status": "Active",
      "LastUpdate": "2016-01-29",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20261231",
      "StartMarketingDatePackage": "20151111",
      "SamplePackage": "N",
      "IndicationAndUsage": "relieves: acid indigestion, heartburn."
    },
    {
      "NDCCode": "21130-017-68",
      "PackageDescription": "1656 mL in 1 BOTTLE, PLASTIC (21130-017-68) ",
      "NDC11Code": "21130-0017-68",
      "ProductNDC": "21130-017",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Hand Wash",
      "NonProprietaryName": "Benzalkonium Chloride",
      "DosageFormName": "SOAP",
      "RouteName": "TOPICAL",
      "StartMarketingDate": "20150728",
      "MarketingCategoryName": "OTC MONOGRAPH DRUG",
      "ApplicationNumber": "505G(a)(3)",
      "LabelerName": "Better Living Brands LLC",
      "SubstanceName": "BENZALKONIUM CHLORIDE",
      "StrengthNumber": "1.3",
      "StrengthUnit": "mg/mL",
      "Status": "Deprecated",
      "LastUpdate": "2024-10-26",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20251231",
      "StartMarketingDatePackage": "20150728",
      "SamplePackage": "N",
      "IndicationAndUsage": "for handwashing to decrease bacteria on the skin."
    },
    {
      "NDCCode": "21130-171-68",
      "PackageDescription": "72 TABLET, CHEWABLE in 1 BOTTLE (21130-171-68) ",
      "NDC11Code": "21130-0171-68",
      "ProductNDC": "21130-171",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Ultra Strength Antacid Relief Assorted Fruit",
      "NonProprietaryName": "Calcium Antacid",
      "DosageFormName": "TABLET, CHEWABLE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20150808",
      "MarketingCategoryName": "OTC MONOGRAPH FINAL",
      "ApplicationNumber": "part331",
      "LabelerName": "Safeway",
      "SubstanceName": "CALCIUM CARBONATE",
      "StrengthNumber": "1000",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2024-01-02",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20231231",
      "StartMarketingDatePackage": "20150808",
      "SamplePackage": "N",
      "IndicationAndUsage": "relieves: 1 acid indigestion, 2 heartburn."
    },
    {
      "NDCCode": "21130-421-68",
      "PackageDescription": "18 POUCH in 1 CARTON (21130-421-68)  / 2 TABLET, EFFERVESCENT in 1 POUCH",
      "NDC11Code": "21130-0421-68",
      "ProductNDC": "21130-421",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Signature Care Effervescent Antacid And Pain Relief",
      "NonProprietaryName": "Aspirin, Citric Acid, Sodium Bicarbonate",
      "DosageFormName": "TABLET, EFFERVESCENT",
      "RouteName": "ORAL",
      "StartMarketingDate": "20150612",
      "EndMarketingDate": "20261231",
      "MarketingCategoryName": "OTC MONOGRAPH DRUG",
      "ApplicationNumber": "M013",
      "LabelerName": "Safeway, Inc",
      "SubstanceName": "SODIUM BICARBONATE; ANHYDROUS CITRIC ACID; ASPIRIN",
      "StrengthNumber": "1916; 1000; 325",
      "StrengthUnit": "mg/1; mg/1; mg/1",
      "Pharm_Classes": "Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]",
      "Status": "Active",
      "LastUpdate": "2024-12-13",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "StartMarketingDatePackage": "20150612",
      "EndMarketingDatePackage": "20261231",
      "SamplePackage": "N",
      "IndicationAndUsage": "Uses for the temporary relief of. ■ heartburn, acid indigestion and sour stomach when accompanied by headache or body aches and pains. ■ upset stomach with headache from overindulgence in food or drink. ■ pain alone (headaches or body aches and pains)."
    },
    {
      "NDCCode": "21130-733-68",
      "PackageDescription": "454 g in 1 BOTTLE (21130-733-68) ",
      "NDC11Code": "21130-0733-68",
      "ProductNDC": "21130-733",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Signature Care Aloe Vera Gel With Lidocaine",
      "NonProprietaryName": "Lidocaine",
      "DosageFormName": "GEL",
      "RouteName": "TOPICAL",
      "StartMarketingDate": "20111214",
      "MarketingCategoryName": "OTC MONOGRAPH DRUG",
      "ApplicationNumber": "M017",
      "LabelerName": "Safeway, Inc.",
      "SubstanceName": "LIDOCAINE HYDROCHLORIDE",
      "StrengthNumber": "8",
      "StrengthUnit": "mg/g",
      "Pharm_Classes": "Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",
      "Status": "Active",
      "LastUpdate": "2025-08-16",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20111214",
      "SamplePackage": "N",
      "IndicationAndUsage": "For the temporary relief of pain and itching associated with sunburn, minor burns, minor cuts, scrapes, insect bites, and minor skin irritations."
    },
    {
      "NDCCode": "21130-971-68",
      "PackageDescription": "72 TABLET, CHEWABLE in 1 BOTTLE (21130-971-68) ",
      "NDC11Code": "21130-0971-68",
      "ProductNDC": "21130-971",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Ultra Strength Antacid Relief Assorted Berry",
      "NonProprietaryName": "Calcium Carbonate",
      "DosageFormName": "TABLET, CHEWABLE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20150808",
      "MarketingCategoryName": "OTC MONOGRAPH FINAL",
      "ApplicationNumber": "part331",
      "LabelerName": "Safeway",
      "SubstanceName": "CALCIUM CARBONATE",
      "StrengthNumber": "1000",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2024-01-02",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20231231",
      "StartMarketingDatePackage": "20150808",
      "SamplePackage": "N",
      "IndicationAndUsage": "relieves: 1 acid indigestion, 2 heartburn."
    },
    {
      "NDCCode": "0597-0146-18",
      "PackageDescription": "180 TABLET, FILM COATED in 1 BOTTLE (0597-0146-18) ",
      "NDC11Code": "00597-0146-18",
      "ProductNDC": "0597-0146",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20120213",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201281",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 500",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20120213",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO is not recommended in patients with type 1 diabetes mellitus. JENTADUETO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO. JENTADUETO is available for oral administration as tablets containing: 1 2.5 mg linagliptin and 500 mg metformin HCl (equivalent to 389.93 mg of metformin), 2 2.5 mg linagliptin and 850 mg metformin HCl (equivalent 662.88 mg of metformin), 3 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0146-60",
      "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (0597-0146-60) ",
      "NDC11Code": "00597-0146-60",
      "ProductNDC": "0597-0146",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20120213",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201281",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 500",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20120213",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO is not recommended in patients with type 1 diabetes mellitus. JENTADUETO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO. JENTADUETO is available for oral administration as tablets containing: 1 2.5 mg linagliptin and 500 mg metformin HCl (equivalent to 389.93 mg of metformin), 2 2.5 mg linagliptin and 850 mg metformin HCl (equivalent 662.88 mg of metformin), 3 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0147-18",
      "PackageDescription": "180 TABLET, FILM COATED in 1 BOTTLE (0597-0147-18) ",
      "NDC11Code": "00597-0147-18",
      "ProductNDC": "0597-0147",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20120213",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201281",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 850",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20120213",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO is not recommended in patients with type 1 diabetes mellitus. JENTADUETO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO. JENTADUETO is available for oral administration as tablets containing: 1 2.5 mg linagliptin and 500 mg metformin HCl (equivalent to 389.93 mg of metformin), 2 2.5 mg linagliptin and 850 mg metformin HCl (equivalent 662.88 mg of metformin), 3 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0147-60",
      "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (0597-0147-60) ",
      "NDC11Code": "00597-0147-60",
      "ProductNDC": "0597-0147",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20120213",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201281",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 850",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20120213",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO is not recommended in patients with type 1 diabetes mellitus. JENTADUETO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO. JENTADUETO is available for oral administration as tablets containing: 1 2.5 mg linagliptin and 500 mg metformin HCl (equivalent to 389.93 mg of metformin), 2 2.5 mg linagliptin and 850 mg metformin HCl (equivalent 662.88 mg of metformin), 3 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0148-18",
      "PackageDescription": "180 TABLET, FILM COATED in 1 BOTTLE (0597-0148-18) ",
      "NDC11Code": "00597-0148-18",
      "ProductNDC": "0597-0148",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20120213",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201281",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20120213",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO is not recommended in patients with type 1 diabetes mellitus. JENTADUETO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO. JENTADUETO is available for oral administration as tablets containing: 1 2.5 mg linagliptin and 500 mg metformin HCl (equivalent to 389.93 mg of metformin), 2 2.5 mg linagliptin and 850 mg metformin HCl (equivalent 662.88 mg of metformin), 3 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0148-60",
      "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (0597-0148-60) ",
      "NDC11Code": "00597-0148-60",
      "ProductNDC": "0597-0148",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20120213",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201281",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20120213",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO is not recommended in patients with type 1 diabetes mellitus. JENTADUETO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO. JENTADUETO is available for oral administration as tablets containing: 1 2.5 mg linagliptin and 500 mg metformin HCl (equivalent to 389.93 mg of metformin), 2 2.5 mg linagliptin and 850 mg metformin HCl (equivalent 662.88 mg of metformin), 3 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0270-73",
      "PackageDescription": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0597-0270-73) ",
      "NDC11Code": "00597-0270-73",
      "ProductNDC": "0597-0270",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto Xr",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20160527",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA208026",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20160527",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO XR is not recommended in patients with type 1 diabetes mellitus. JENTADUETO XR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO XR [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO XR tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is:. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO XR consists of an extended-release metformin core tablet that is coated with the immediate-release drug substance linagliptin. JENTADUETO XR is available for oral administration as tablets containing: 1 5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin), 2 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0270-94",
      "PackageDescription": "180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0597-0270-94) ",
      "NDC11Code": "00597-0270-94",
      "ProductNDC": "0597-0270",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto Xr",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20160527",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA208026",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20160527",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO XR is not recommended in patients with type 1 diabetes mellitus. JENTADUETO XR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO XR [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO XR tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is:. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO XR consists of an extended-release metformin core tablet that is coated with the immediate-release drug substance linagliptin. JENTADUETO XR is available for oral administration as tablets containing: 1 5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin), 2 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0275-33",
      "PackageDescription": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0597-0275-33) ",
      "NDC11Code": "00597-0275-33",
      "ProductNDC": "0597-0275",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto Xr",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20160527",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA208026",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20160527",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO XR is not recommended in patients with type 1 diabetes mellitus. JENTADUETO XR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO XR [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO XR tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is:. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO XR consists of an extended-release metformin core tablet that is coated with the immediate-release drug substance linagliptin. JENTADUETO XR is available for oral administration as tablets containing: 1 5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin), 2 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "0597-0275-81",
      "PackageDescription": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0597-0275-81) ",
      "NDC11Code": "00597-0275-81",
      "ProductNDC": "0597-0275",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto Xr",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20160527",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA208026",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2026-08-27",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20160527",
      "SamplePackage": "N",
      "IndicationAndUsage": "JENTADUETO XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use. JENTADUETO XR is not recommended in patients with type 1 diabetes mellitus. JENTADUETO XR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO XR [see Warnings and Precautions (5.2)].",
      "Description": "JENTADUETO XR tablets for oral use contain: linagliptin and metformin HCl. Linagliptin. Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is:. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin HCl. Metformin HCl (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin HCl is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63 g/mol. Metformin HCl is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO XR consists of an extended-release metformin core tablet that is coated with the immediate-release drug substance linagliptin. JENTADUETO XR is available for oral administration as tablets containing: 1 5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin), 2 2.5 mg linagliptin and 1,000 mg metformin HCl (equivalent to 779.86 mg of metformin)."
    },
    {
      "NDCCode": "21695-472-30",
      "PackageDescription": "30 TABLET in 1 BOTTLE (21695-472-30)",
      "NDC11Code": "21695-0472-30",
      "ProductNDC": "21695-472",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Metformin Hydrochloride",
      "NonProprietaryName": "Metformin Hydrochloride",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20020129",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA075967",
      "LabelerName": "Rebel Distributors Corp.",
      "SubstanceName": "METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "850",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Biguanide [EPC],Biguanides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2019-09-21",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Metformin hydrochloride tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus.",
      "Description": "Metformin hydrochloride, USP is an oral antihyperglycemic drug used in the management of type 2 diabetes. Metformin hydrochloride ( N,N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. The structural formula is as shown:. Metformin hydrochloride, USP is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63. Metformin hydrochloride, USP is freely soluble in water and is practically insoluble in acetone, ether and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride, USP is 6.68. Metformin hydrochloride tablets, USP contain 500 mg, 850 mg, and 1000 mg of metformin hydrochloride, USP. Each tablet contains the inactive ingredients povidone, polyethylene glycol and magnesium stearate. In addition, the coating for 500 mg, 850 mg and 1000 mg contains:lactose monohydrate,hypromellose,titanium dioxide,triacetin."
    },
    {
      "NDCCode": "21695-472-60",
      "PackageDescription": "60 TABLET in 1 BOTTLE (21695-472-60)",
      "NDC11Code": "21695-0472-60",
      "ProductNDC": "21695-472",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Metformin Hydrochloride",
      "NonProprietaryName": "Metformin Hydrochloride",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20020129",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA075967",
      "LabelerName": "Rebel Distributors Corp.",
      "SubstanceName": "METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "850",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Biguanide [EPC],Biguanides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2019-09-21",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Metformin hydrochloride tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus.",
      "Description": "Metformin hydrochloride, USP is an oral antihyperglycemic drug used in the management of type 2 diabetes. Metformin hydrochloride ( N,N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. The structural formula is as shown:. Metformin hydrochloride, USP is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63. Metformin hydrochloride, USP is freely soluble in water and is practically insoluble in acetone, ether and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride, USP is 6.68. Metformin hydrochloride tablets, USP contain 500 mg, 850 mg, and 1000 mg of metformin hydrochloride, USP. Each tablet contains the inactive ingredients povidone, polyethylene glycol and magnesium stearate. In addition, the coating for 500 mg, 850 mg and 1000 mg contains:lactose monohydrate,hypromellose,titanium dioxide,triacetin."
    },
    {
      "NDCCode": "54868-6461-0",
      "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (54868-6461-0)",
      "NDC11Code": "54868-6461-00",
      "ProductNDC": "54868-6461",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Jentadueto",
      "NonProprietaryName": "Linagliptin",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20120213",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201281",
      "LabelerName": "Physicians Total Care, Inc.",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Biguanide [EPC],Biguanides [Chemical/Ingredient]",
      "Status": "Deprecated",
      "LastUpdate": "2018-07-24",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "JENTADUETO is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate (1.1). Important limitations of use: 1 Not for treatment of type 1 diabetes or diabetic ketoacidosis (1.2), 2 Has not been studied in patients with a history of pancreatitis (1.2).",
      "Description": "JENTADUETO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 diabetes mellitus: linagliptin and metformin hydrochloride. Linagliptin. Linagliptin is an orally-active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. Linagliptin is described chemically as 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The empirical formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Metformin Hydrochloride. Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. JENTADUETO. JENTADUETO is available for oral administration as tablets containing 2.5 mg linagliptin and 500 mg metformin hydrochloride (JENTADUETO 2.5 mg/500 mg), 850 mg metformin hydrochloride (JENTADUETO 2.5 mg/850 mg) or 1000 mg metformin hydrochloride (JENTADUETO 2.5 mg/1000 mg). Each film-coated tablet of JENTADUETO contains the following inactive ingredients: arginine, corn starch, copovidone, colloidal silicon dioxide, magnesium stearate, titanium dioxide, propylene glycol, hypromellose, talc, yellow ferric oxide (2.5 mg/500 mg; 2.5 mg/850 mg) and/or red ferric oxide (2.5 mg/850 mg; 2.5 mg/1000 mg)."
    },
    {
      "NDCCode": "72205-407-01",
      "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01) ",
      "NDC11Code": "72205-0407-01",
      "ProductNDC": "72205-407",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20251103",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA208459",
      "LabelerName": "Novadoz Pharmaceuticals LLC",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 500",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-11-06",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20251104",
      "SamplePackage": "N",
      "IndicationAndUsage": "Linagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of Use Linagliptin and metformin hydrochloride tablets are not recommended in patients with type 1 diabetes mellitus. Linagliptin and metformin hydrochloride tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using linagliptin and metformin hydrochloride tablets [see Warnings and Precautions (5.2)].",
      "Description": "Linagliptin and metformin hydrochloride tablets for oral use contain: linagliptin and metformin hydrochloride.Linagliptin Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca.1 mg/mL). Metformin Hydrochloride  Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63 g/mol. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. Linagliptin and Metformin Hydrochloride Tablets. Linagliptin and metformin hydrochloride tablets are available for oral administration as tablets containing:     2.5 mg linagliptin and 500 mg metformin hydrochloride (equivalent to 389.93 mg of metformin)     2.5 mg linagliptin and 850 mg metformin hydrochloride (equivalent 662.88 mg of metformin)     2.5 mg linagliptin and 1,000 mg metformin hydrochloride (equivalent to 779.86 mg of metformin) Each film-coated tablet of linagliptin and metformin hydrochloride tablets contains the following inactive ingredients: colloidal silicon dioxide, copovidone, corn starch, hypromellose, magnesium stearate, meglumine, povidone, propylene glycol, titanium dioxide, talc, yellow iron oxide (2.5 mg/500 mg; 2.5 mg/850 mg) and/or red iron oxide (2.5 mg/850 mg; 2.5 mg/1,000 mg)."
    },
    {
      "NDCCode": "72205-407-02",
      "PackageDescription": "180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02) ",
      "NDC11Code": "72205-0407-02",
      "ProductNDC": "72205-407",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20251103",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA208459",
      "LabelerName": "Novadoz Pharmaceuticals LLC",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 500",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-11-06",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20251104",
      "SamplePackage": "N",
      "IndicationAndUsage": "Linagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of Use Linagliptin and metformin hydrochloride tablets are not recommended in patients with type 1 diabetes mellitus. Linagliptin and metformin hydrochloride tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using linagliptin and metformin hydrochloride tablets [see Warnings and Precautions (5.2)].",
      "Description": "Linagliptin and metformin hydrochloride tablets for oral use contain: linagliptin and metformin hydrochloride.Linagliptin Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca.1 mg/mL). Metformin Hydrochloride  Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63 g/mol. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. Linagliptin and Metformin Hydrochloride Tablets. Linagliptin and metformin hydrochloride tablets are available for oral administration as tablets containing:     2.5 mg linagliptin and 500 mg metformin hydrochloride (equivalent to 389.93 mg of metformin)     2.5 mg linagliptin and 850 mg metformin hydrochloride (equivalent 662.88 mg of metformin)     2.5 mg linagliptin and 1,000 mg metformin hydrochloride (equivalent to 779.86 mg of metformin) Each film-coated tablet of linagliptin and metformin hydrochloride tablets contains the following inactive ingredients: colloidal silicon dioxide, copovidone, corn starch, hypromellose, magnesium stearate, meglumine, povidone, propylene glycol, titanium dioxide, talc, yellow iron oxide (2.5 mg/500 mg; 2.5 mg/850 mg) and/or red iron oxide (2.5 mg/850 mg; 2.5 mg/1,000 mg)."
    },
    {
      "NDCCode": "72205-408-01",
      "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (72205-408-01) ",
      "NDC11Code": "72205-0408-01",
      "ProductNDC": "72205-408",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20251103",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA208459",
      "LabelerName": "Novadoz Pharmaceuticals LLC",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 850",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-11-06",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20251104",
      "SamplePackage": "N",
      "IndicationAndUsage": "Linagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of Use Linagliptin and metformin hydrochloride tablets are not recommended in patients with type 1 diabetes mellitus. Linagliptin and metformin hydrochloride tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using linagliptin and metformin hydrochloride tablets [see Warnings and Precautions (5.2)].",
      "Description": "Linagliptin and metformin hydrochloride tablets for oral use contain: linagliptin and metformin hydrochloride.Linagliptin Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca.1 mg/mL). Metformin Hydrochloride  Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63 g/mol. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. Linagliptin and Metformin Hydrochloride Tablets. Linagliptin and metformin hydrochloride tablets are available for oral administration as tablets containing:     2.5 mg linagliptin and 500 mg metformin hydrochloride (equivalent to 389.93 mg of metformin)     2.5 mg linagliptin and 850 mg metformin hydrochloride (equivalent 662.88 mg of metformin)     2.5 mg linagliptin and 1,000 mg metformin hydrochloride (equivalent to 779.86 mg of metformin) Each film-coated tablet of linagliptin and metformin hydrochloride tablets contains the following inactive ingredients: colloidal silicon dioxide, copovidone, corn starch, hypromellose, magnesium stearate, meglumine, povidone, propylene glycol, titanium dioxide, talc, yellow iron oxide (2.5 mg/500 mg; 2.5 mg/850 mg) and/or red iron oxide (2.5 mg/850 mg; 2.5 mg/1,000 mg)."
    },
    {
      "NDCCode": "72205-408-02",
      "PackageDescription": "180 TABLET, FILM COATED in 1 BOTTLE (72205-408-02) ",
      "NDC11Code": "72205-0408-02",
      "ProductNDC": "72205-408",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20251103",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA208459",
      "LabelerName": "Novadoz Pharmaceuticals LLC",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 850",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-11-06",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20251104",
      "SamplePackage": "N",
      "IndicationAndUsage": "Linagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of Use Linagliptin and metformin hydrochloride tablets are not recommended in patients with type 1 diabetes mellitus. Linagliptin and metformin hydrochloride tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using linagliptin and metformin hydrochloride tablets [see Warnings and Precautions (5.2)].",
      "Description": "Linagliptin and metformin hydrochloride tablets for oral use contain: linagliptin and metformin hydrochloride.Linagliptin Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca.1 mg/mL). Metformin Hydrochloride  Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63 g/mol. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. Linagliptin and Metformin Hydrochloride Tablets. Linagliptin and metformin hydrochloride tablets are available for oral administration as tablets containing:     2.5 mg linagliptin and 500 mg metformin hydrochloride (equivalent to 389.93 mg of metformin)     2.5 mg linagliptin and 850 mg metformin hydrochloride (equivalent 662.88 mg of metformin)     2.5 mg linagliptin and 1,000 mg metformin hydrochloride (equivalent to 779.86 mg of metformin) Each film-coated tablet of linagliptin and metformin hydrochloride tablets contains the following inactive ingredients: colloidal silicon dioxide, copovidone, corn starch, hypromellose, magnesium stearate, meglumine, povidone, propylene glycol, titanium dioxide, talc, yellow iron oxide (2.5 mg/500 mg; 2.5 mg/850 mg) and/or red iron oxide (2.5 mg/850 mg; 2.5 mg/1,000 mg)."
    },
    {
      "NDCCode": "72205-409-01",
      "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (72205-409-01) ",
      "NDC11Code": "72205-0409-01",
      "ProductNDC": "72205-409",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20251103",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA208459",
      "LabelerName": "Novadoz Pharmaceuticals LLC",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-11-06",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20251104",
      "SamplePackage": "N",
      "IndicationAndUsage": "Linagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of Use Linagliptin and metformin hydrochloride tablets are not recommended in patients with type 1 diabetes mellitus. Linagliptin and metformin hydrochloride tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using linagliptin and metformin hydrochloride tablets [see Warnings and Precautions (5.2)].",
      "Description": "Linagliptin and metformin hydrochloride tablets for oral use contain: linagliptin and metformin hydrochloride.Linagliptin Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca.1 mg/mL). Metformin Hydrochloride  Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63 g/mol. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. Linagliptin and Metformin Hydrochloride Tablets. Linagliptin and metformin hydrochloride tablets are available for oral administration as tablets containing:     2.5 mg linagliptin and 500 mg metformin hydrochloride (equivalent to 389.93 mg of metformin)     2.5 mg linagliptin and 850 mg metformin hydrochloride (equivalent 662.88 mg of metformin)     2.5 mg linagliptin and 1,000 mg metformin hydrochloride (equivalent to 779.86 mg of metformin) Each film-coated tablet of linagliptin and metformin hydrochloride tablets contains the following inactive ingredients: colloidal silicon dioxide, copovidone, corn starch, hypromellose, magnesium stearate, meglumine, povidone, propylene glycol, titanium dioxide, talc, yellow iron oxide (2.5 mg/500 mg; 2.5 mg/850 mg) and/or red iron oxide (2.5 mg/850 mg; 2.5 mg/1,000 mg)."
    },
    {
      "NDCCode": "72205-409-02",
      "PackageDescription": "180 TABLET, FILM COATED in 1 BOTTLE (72205-409-02) ",
      "NDC11Code": "72205-0409-02",
      "ProductNDC": "72205-409",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "NonProprietaryName": "Linagliptin And Metformin Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20251103",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA208459",
      "LabelerName": "Novadoz Pharmaceuticals LLC",
      "SubstanceName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "2.5; 1000",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-11-06",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20251104",
      "SamplePackage": "N",
      "IndicationAndUsage": "Linagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of Use Linagliptin and metformin hydrochloride tablets are not recommended in patients with type 1 diabetes mellitus. Linagliptin and metformin hydrochloride tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using linagliptin and metformin hydrochloride tablets [see Warnings and Precautions (5.2)].",
      "Description": "Linagliptin and metformin hydrochloride tablets for oral use contain: linagliptin and metformin hydrochloride.Linagliptin Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca.1 mg/mL). Metformin Hydrochloride  Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5HCl and a molecular weight of 165.63 g/mol. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is. Linagliptin and Metformin Hydrochloride Tablets. Linagliptin and metformin hydrochloride tablets are available for oral administration as tablets containing:     2.5 mg linagliptin and 500 mg metformin hydrochloride (equivalent to 389.93 mg of metformin)     2.5 mg linagliptin and 850 mg metformin hydrochloride (equivalent 662.88 mg of metformin)     2.5 mg linagliptin and 1,000 mg metformin hydrochloride (equivalent to 779.86 mg of metformin) Each film-coated tablet of linagliptin and metformin hydrochloride tablets contains the following inactive ingredients: colloidal silicon dioxide, copovidone, corn starch, hypromellose, magnesium stearate, meglumine, povidone, propylene glycol, titanium dioxide, talc, yellow iron oxide (2.5 mg/500 mg; 2.5 mg/850 mg) and/or red iron oxide (2.5 mg/850 mg; 2.5 mg/1,000 mg)."
    },
    {
      "NDCCode": "72789-472-01",
      "PackageDescription": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-472-01) ",
      "NDC11Code": "72789-0472-01",
      "ProductNDC": "72789-472",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Metformin Hydrochloride",
      "NonProprietaryName": "Metformin Hydrochloride",
      "DosageFormName": "TABLET, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20181027",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA206145",
      "LabelerName": "PD-Rx Pharmaceuticals, Inc.",
      "SubstanceName": "METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "750",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS]",
      "Status": "Active",
      "LastUpdate": "2026-01-22",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20250115",
      "SamplePackage": "N",
      "IndicationAndUsage": "Metformin hydrochloride tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
      "Description": "Metformin hydrochloride tablets and metformin hydrochloride extended-release tablets contain the antihyperglycemic agent metformin, which is a biguanide, in the form of monohydrochloride. The chemical name of metformin hydrochloride is N,N-dimethylimidodicarbonimidic diamide hydrochloride. The structural formula is as shown below:. Metformin hydrochloride USP is a white to off-white crystalline compound with a molecular formula of C 4H 11N 5 HCl and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. Metformin hydrochloride tablets USP contain 500 mg, 850 mg, or 1,000 mg of metformin hydrochloride USP. Each tablet contains the inactive ingredients corn starch, povidone and magnesium stearate. In addition, the coating for each tablet contains hypromellose, talc, titanium dioxide, polyethylene glycol, and propylene glycol. Metformin hydrochloride extended-release tablets, USP contains 500 mg or 750 mg of metformin hydrochloride as the active ingredient. Metformin hydrochloride extended-release tablets USP, 500 mg and 750 mg contain the inactive ingredients sodium carboxymethyl cellulose, hypromellose, microcrystalline cellulose, magnesium stearate and copovidone. FDA approved dissolution test specifications differ from USP."
    },
    {
      "NDCCode": "72789-472-82",
      "PackageDescription": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-472-82) ",
      "NDC11Code": "72789-0472-82",
      "ProductNDC": "72789-472",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Metformin Hydrochloride",
      "NonProprietaryName": "Metformin Hydrochloride",
      "DosageFormName": "TABLET, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20181027",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA206145",
      "LabelerName": "PD-Rx Pharmaceuticals, Inc.",
      "SubstanceName": "METFORMIN HYDROCHLORIDE",
      "StrengthNumber": "750",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Biguanide [EPC], Biguanides [CS]",
      "Status": "Active",
      "LastUpdate": "2026-01-22",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20250115",
      "SamplePackage": "N",
      "IndicationAndUsage": "Metformin hydrochloride tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
      "Description": "Metformin hydrochloride tablets and metformin hydrochloride extended-release tablets contain the antihyperglycemic agent metformin, which is a biguanide, in the form of monohydrochloride. The chemical name of metformin hydrochloride is N,N-dimethylimidodicarbonimidic diamide hydrochloride. The structural formula is as shown below:. Metformin hydrochloride USP is a white to off-white crystalline compound with a molecular formula of C 4H 11N 5 HCl and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. Metformin hydrochloride tablets USP contain 500 mg, 850 mg, or 1,000 mg of metformin hydrochloride USP. Each tablet contains the inactive ingredients corn starch, povidone and magnesium stearate. In addition, the coating for each tablet contains hypromellose, talc, titanium dioxide, polyethylene glycol, and propylene glycol. Metformin hydrochloride extended-release tablets, USP contains 500 mg or 750 mg of metformin hydrochloride as the active ingredient. Metformin hydrochloride extended-release tablets USP, 500 mg and 750 mg contain the inactive ingredients sodium carboxymethyl cellulose, hypromellose, microcrystalline cellulose, magnesium stearate and copovidone. FDA approved dissolution test specifications differ from USP."
    },
    {
      "NDCCode": "0597-0140-30",
      "PackageDescription": "30 TABLET, FILM COATED in 1 BOTTLE (0597-0140-30) ",
      "NDC11Code": "00597-0140-30",
      "ProductNDC": "0597-0140",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Tradjenta",
      "NonProprietaryName": "Linagliptin",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20110509",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201280",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN",
      "StrengthNumber": "5",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-04-02",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20261231",
      "StartMarketingDatePackage": "20110509",
      "SamplePackage": "N",
      "IndicationAndUsage": "TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
      "Description": "TRADJENTA tablets for oral use contain linagliptin, an inhibitor of the DPP-4 enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Each film-coated tablet of TRADJENTA contains 5 mg of linagliptin free base and the following inactive ingredients: copovidone, corn starch, magnesium stearate, mannitol, and pregelatinized starch. In addition, the film coating contains the following inactive ingredients: hypromellose, polyethylene glycol, red ferric oxide, talc, and titanium dioxide."
    },
    {
      "NDCCode": "0597-0140-61",
      "PackageDescription": "100 BLISTER PACK in 1 CARTON (0597-0140-61)  / 1 TABLET, FILM COATED in 1 BLISTER PACK",
      "NDC11Code": "00597-0140-61",
      "ProductNDC": "0597-0140",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Tradjenta",
      "NonProprietaryName": "Linagliptin",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20110509",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201280",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN",
      "StrengthNumber": "5",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Active",
      "LastUpdate": "2025-04-02",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20261231",
      "StartMarketingDatePackage": "20110509",
      "SamplePackage": "N",
      "IndicationAndUsage": "TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
      "Description": "TRADJENTA tablets for oral use contain linagliptin, an inhibitor of the DPP-4 enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Each film-coated tablet of TRADJENTA contains 5 mg of linagliptin free base and the following inactive ingredients: copovidone, corn starch, magnesium stearate, mannitol, and pregelatinized starch. In addition, the film coating contains the following inactive ingredients: hypromellose, polyethylene glycol, red ferric oxide, talc, and titanium dioxide."
    },
    {
      "NDCCode": "0597-0140-70",
      "PackageDescription": "7 BLISTER PACK in 1 CARTON (0597-0140-70)  / 1 TABLET, FILM COATED in 1 BLISTER PACK",
      "NDC11Code": "00597-0140-70",
      "ProductNDC": "0597-0140",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Tradjenta",
      "NonProprietaryName": "Linagliptin",
      "DosageFormName": "TABLET, FILM COATED",
      "RouteName": "ORAL",
      "StartMarketingDate": "20110509",
      "MarketingCategoryName": "NDA",
      "ApplicationNumber": "NDA201280",
      "LabelerName": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "SubstanceName": "LINAGLIPTIN",
      "StrengthNumber": "5",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2026-09-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20261231",
      "StartMarketingDatePackage": "20110509",
      "EndMarketingDatePackage": "20260831",
      "SamplePackage": "Y",
      "IndicationAndUsage": "TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
      "Description": "TRADJENTA tablets for oral use contain linagliptin, an inhibitor of the DPP-4 enzyme. The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. The molecular formula is C25H28N8O2 and the molecular weight is 472.54 g/mol. The structural formula is. Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water (0.9 mg/mL). Linagliptin is soluble in methanol (ca. 60 mg/mL), sparingly soluble in ethanol (ca. 10 mg/mL), very slightly soluble in isopropanol (<1 mg/mL), and very slightly soluble in acetone (ca. 1 mg/mL). Each film-coated tablet of TRADJENTA contains 5 mg of linagliptin free base and the following inactive ingredients: copovidone, corn starch, magnesium stearate, mannitol, and pregelatinized starch. In addition, the film coating contains the following inactive ingredients: hypromellose, polyethylene glycol, red ferric oxide, talc, and titanium dioxide."
    }
  ]
}
                    

{"NDC":[{"NDCCode":"21130-472-68","ProprietaryName":"Antacid Relief","NonProprietaryName":"Calcium Carbonate"},{"NDCCode":"21130-017-68","ProprietaryName":"Hand Wash","NonProprietaryName":"Benzalkonium Chloride"},{"NDCCode":"21130-171-68","ProprietaryName":"Ultra Strength Antacid Relief Assorted Fruit","NonProprietaryName":"Calcium Antacid"},{"NDCCode":"21130-421-68","ProprietaryName":"Signature Care Effervescent Antacid And Pain Relief","NonProprietaryName":"Aspirin, Citric Acid, Sodium Bicarbonate"},{"NDCCode":"21130-733-68","ProprietaryName":"Signature Care Aloe Vera Gel With Lidocaine","NonProprietaryName":"Lidocaine"},{"NDCCode":"21130-971-68","ProprietaryName":"Ultra Strength Antacid Relief Assorted Berry","NonProprietaryName":"Calcium Carbonate"},{"NDCCode":"0597-0146-18","ProprietaryName":"Jentadueto","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0146-60","ProprietaryName":"Jentadueto","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0147-18","ProprietaryName":"Jentadueto","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0147-60","ProprietaryName":"Jentadueto","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0148-18","ProprietaryName":"Jentadueto","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0148-60","ProprietaryName":"Jentadueto","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0270-73","ProprietaryName":"Jentadueto Xr","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0270-94","ProprietaryName":"Jentadueto Xr","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0275-33","ProprietaryName":"Jentadueto Xr","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"0597-0275-81","ProprietaryName":"Jentadueto Xr","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"21695-472-30","ProprietaryName":"Metformin Hydrochloride","NonProprietaryName":"Metformin Hydrochloride"},{"NDCCode":"21695-472-60","ProprietaryName":"Metformin Hydrochloride","NonProprietaryName":"Metformin Hydrochloride"},{"NDCCode":"54868-6461-0","ProprietaryName":"Jentadueto","NonProprietaryName":"Linagliptin"},{"NDCCode":"72205-407-01","ProprietaryName":"Linagliptin And Metformin Hydrochloride","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"72205-407-02","ProprietaryName":"Linagliptin And Metformin Hydrochloride","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"72205-408-01","ProprietaryName":"Linagliptin And Metformin Hydrochloride","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"72205-408-02","ProprietaryName":"Linagliptin And Metformin Hydrochloride","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"72205-409-01","ProprietaryName":"Linagliptin And Metformin Hydrochloride","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"72205-409-02","ProprietaryName":"Linagliptin And Metformin Hydrochloride","NonProprietaryName":"Linagliptin And Metformin Hydrochloride"},{"NDCCode":"72789-472-01","ProprietaryName":"Metformin Hydrochloride","NonProprietaryName":"Metformin Hydrochloride"},{"NDCCode":"72789-472-82","ProprietaryName":"Metformin Hydrochloride","NonProprietaryName":"Metformin Hydrochloride"},{"NDCCode":"0597-0140-30","ProprietaryName":"Tradjenta","NonProprietaryName":"Linagliptin"},{"NDCCode":"0597-0140-61","ProprietaryName":"Tradjenta","NonProprietaryName":"Linagliptin"},{"NDCCode":"0597-0140-70","ProprietaryName":"Tradjenta","NonProprietaryName":"Linagliptin"}]}
                    

<NDCList><NDC><NDCCode>21130-472-68</NDCCode><ProprietaryName>Antacid Relief</ProprietaryName><NonProprietaryName>Calcium Carbonate</NonProprietaryName></NDC><NDC><NDCCode>21130-017-68</NDCCode><ProprietaryName>Hand Wash</ProprietaryName><NonProprietaryName>Benzalkonium Chloride</NonProprietaryName></NDC><NDC><NDCCode>21130-171-68</NDCCode><ProprietaryName>Ultra Strength Antacid Relief Assorted Fruit</ProprietaryName><NonProprietaryName>Calcium Antacid</NonProprietaryName></NDC><NDC><NDCCode>21130-421-68</NDCCode><ProprietaryName>Signature Care Effervescent Antacid And Pain Relief</ProprietaryName><NonProprietaryName>Aspirin, Citric Acid, Sodium Bicarbonate</NonProprietaryName></NDC><NDC><NDCCode>21130-733-68</NDCCode><ProprietaryName>Signature Care Aloe Vera Gel With Lidocaine</ProprietaryName><NonProprietaryName>Lidocaine</NonProprietaryName></NDC><NDC><NDCCode>21130-971-68</NDCCode><ProprietaryName>Ultra Strength Antacid Relief Assorted Berry</ProprietaryName><NonProprietaryName>Calcium Carbonate</NonProprietaryName></NDC><NDC><NDCCode>0597-0146-18</NDCCode><ProprietaryName>Jentadueto</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0146-60</NDCCode><ProprietaryName>Jentadueto</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0147-18</NDCCode><ProprietaryName>Jentadueto</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0147-60</NDCCode><ProprietaryName>Jentadueto</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0148-18</NDCCode><ProprietaryName>Jentadueto</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0148-60</NDCCode><ProprietaryName>Jentadueto</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0270-73</NDCCode><ProprietaryName>Jentadueto Xr</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0270-94</NDCCode><ProprietaryName>Jentadueto Xr</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0275-33</NDCCode><ProprietaryName>Jentadueto Xr</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0275-81</NDCCode><ProprietaryName>Jentadueto Xr</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>21695-472-30</NDCCode><ProprietaryName>Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>21695-472-60</NDCCode><ProprietaryName>Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>54868-6461-0</NDCCode><ProprietaryName>Jentadueto</ProprietaryName><NonProprietaryName>Linagliptin</NonProprietaryName></NDC><NDC><NDCCode>72205-407-01</NDCCode><ProprietaryName>Linagliptin And Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>72205-407-02</NDCCode><ProprietaryName>Linagliptin And Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>72205-408-01</NDCCode><ProprietaryName>Linagliptin And Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>72205-408-02</NDCCode><ProprietaryName>Linagliptin And Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>72205-409-01</NDCCode><ProprietaryName>Linagliptin And Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>72205-409-02</NDCCode><ProprietaryName>Linagliptin And Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Linagliptin And Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>72789-472-01</NDCCode><ProprietaryName>Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>72789-472-82</NDCCode><ProprietaryName>Metformin Hydrochloride</ProprietaryName><NonProprietaryName>Metformin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>0597-0140-30</NDCCode><ProprietaryName>Tradjenta</ProprietaryName><NonProprietaryName>Linagliptin</NonProprietaryName></NDC><NDC><NDCCode>0597-0140-61</NDCCode><ProprietaryName>Tradjenta</ProprietaryName><NonProprietaryName>Linagliptin</NonProprietaryName></NDC><NDC><NDCCode>0597-0140-70</NDCCode><ProprietaryName>Tradjenta</ProprietaryName><NonProprietaryName>Linagliptin</NonProprietaryName></NDC></NDCList>